Skip to content
mp.weixin.qq.com·· 4 hours agoPickScore91

Liu Jianmin Team Publishes MILD-MT and LATE-MT Thrombectomy Trials in New England Journal of Medicine

In brief

Liu Jianmin's team simultaneously published the MILD-MT and LATE-MT results in the New England Journal of Medicine, showing that imaging-selected patients with mild stroke and those presenting 24 to 72 hours after onset can benefit from thrombectomy. MILD-MT screened 638 patients and enrolled 300; the thrombectomy group had better 90-day neurological recovery than best medical therapy, with lower risk of early neurological deterioration within 7 days and no increase in symptomatic intracranial hemorrhage.

Why it matters

Both randomized trials used medical therapy as the control and assessed thrombectomy benefit in mild stroke and efficacy and safety at 24 to 72 hours after onset.

Source: mp.weixin.qq.com · mp.weixin.qq.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org